Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Boehringer Ingelheim is seeking an Executive Director, Computational Biology – Cardio-Renal-Metabolic (CRM) Diseases in Ridgefield to lead computational biology strategies for kidney research and collaborate across Research, Experimental Medicine, Clinical Pharmacology and Safety.
The role integrates human genetics, multi-omics, AI-enabled methods, and translational data to identify opportunities, biomarkers, and patient stratification, guiding decisions from target discovery through proof of
The Executive Director, Computational Biology – Cardio-Renal-Metabolic (CRM) Diseases is a scientific leader responsible for developing and delivering computational biology strategies for kidney research while contributing expertise across the broader CRM portfolio. As part of Computational Innovation in Ridgefield (RDG), the Executive Director will serve as the primary computational biology contact for the local CRM Therapeutic Area and as a key partner to Research, Experimental Medicine, Clinical Pharmacology and Safety. The Executive Director will work in close collaboration with the Global Computational Biology CRM Head and teams to align priorities, share expertise, and enable coordinated delivery across the portfolio.
The Executive Director will guide the integration of human genetics, multi-omics, advanced analytics, AI-enabled methods, and translational data to identify and validate therapeutic opportunities, support indication and patient-segmentation strategies, identify biomarkers, and use computational evidence to inform project decisions from target discovery through proof of concept. The role is accountable for high-quality scientific delivery, effective collaboration, capability development, and computational insights that advance medicines for patients with kidney and related cardio-renal-metabolic diseases.
As a member of the Computational Innovation (CI) Ridgefield leadership team, the Executive Director will help shape site strategy, represent the Computational Biology CRM function, ensure operational excellence across CI functions, and foster a culture of high performance, and Innovation Unit wide collaboration. The Executive Director will strengthen the visibility and impact of Computational Innovation at the Ridgefield site and represent the organization externally through strategic academic and industry partnerships across the United States.
As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides an opportunity for all employees to collaborate internationally, offering visibility and the opportunity to directly contribute to the company's success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.
The Executive Director, Computational Biology – Cardio-Renal-Metabolic (CRM) Diseases is a scientific leader responsible for developing and delivering computational biology strategies for kidney research while contributing expertise across the broader CRM portfolio. As part of Computational Innovation in Ridgefield (RDG), the Executive Director will serve as the primary computational biology contact for the local CRM Therapeutic Area and as a key partner to Research, Experimental Medicine, Clinical Pharmacology and Safety. The Executive Director will work in close collaboration with the Global Computational Biology CRM Head and teams to align priorities, share expertise, and enable coordinated delivery across the portfolio.
The Executive Director will guide the integration of human genetics, multi-omics, advanced analytics, AI-enabled methods, and translational data to identify and validate therapeutic opportunities, support indication and patient-segmentation strategies, identify biomarkers, and use computational evidence to inform project decisions from target discovery through proof of concept. The role is accountable for high-quality scientific delivery, effective collaboration, capability development, and computational insights that advance medicines for patients with kidney and related cardio-renal-metabolic diseases.
As a member of the Computational Innovation (CI) Ridgefield leadership team, the Executive Director will help shape site strategy, represent the Computational Biology CRM function, ensure operational excellence across CI functions, and foster a culture of high performance, and Innovation Unit wide collaboration. The Executive Director will strengthen the visibility and impact of Computational Innovation at the Ridgefield site and represent the organization externally through strategic academic and industry partnerships across the United States.
As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides an opportunity for all employees to collaborate internationally, offering visibility and the opportunity to directly contribute to the company's success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.
The base salary range for this position is $262,400 to $393,600. The position may be eligible for a role- specific discretionary bonus, relocation assistance, and/or other compensation elements. We continuously review market data and may adjust salary ranges as needed in the future. Actual compensation will be based on job-related factors such as skills, experience, qualifications, and other factors permitted by law. Benefits include medical, dental, and vision coverage, retirement savings opportunities, paid time off, paid holidays, disability and life insurance benefits, and other company-sponsored benefits. For additional information regarding our benefits and Total Rewards offerings, please
Boehringer Ing ilheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long- term perspective, embedding sustainability along the entire value chain. Our approximately 54,300 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com.
With us, you can develop your own path in a company with a culture that knows our differences are our strengths - and break new ground in the drive to make millions of lives better.
Here, your development is our priority. Supporting you to build a career as part of a workplace that is independent, authentic and bold, while tackling challenging work in a respectful and friendly environment where everyone is valued and welcomed.
Alongside, you have access to programs and groups that ensure your health and wellbeing are looked after - as we make major investments to drive global accessibility to healthcare. By being part of a team that is constantly innovating, you'll be helping to transform lives for generations.